Delivery Order SPE2DB20D3111-SPE2DB25FA6KB
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,117.04, is a delivery order for 4,567,009,775 units of the prescription medication Vyvanse 50 mg capsule. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,501.86, is for the delivery of Vyvanse 50 mg capsules (100 count) to support military and federal healthcare programs. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,760.92 for the supply of 4,568,165,093 units of Vyvanse 50 mg capsules. The contract has a period of performance extending through May 7, 2025 and is a Firm Fixed Price, non-set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,416.39 and has a completion date of February 7, 2024. The contract is for the supply of 4,563,574,052 units of the medication Vyvanse 30 mg capsules in 100s. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.04, is a Firm Fixed Price Delivery Order for the supply of 4,567,782,172 units of the drug Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm-fixed-price delivery order is for 4,567,860,309 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,085.15, is a Firm Fixed Price delivery order for the supply of 4,567,557,992 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,790.03, is a delivery order for 4,567,539,322 units of the drug Vyvanse 10 mg capsules. The contract is a firm fixed-price agreement with an ultimate completion date of March 12, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,759.37. The award is for the supply of 4,567,887,842 units of the medication Vyvanse 30 mg capsules. The contract has an Ultimate Completion Date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,006.66, is a delivery order for the supply of 4,567,264,038 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 14, 2025 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...